Please use this identifier to cite or link to this item:
Title: Interferon-alpha plus lamivudine vs lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Alanine Transaminase/blood,Antiviral Agents/metabolism/*therapeutic use,DNA, Viral/blood,*Drug Therapy, Combination,Genotype,Hepatitis B e Antigens/*immunology,Hepatitis B, Chronic/*drug therapy/genetics,Humans,Interferon-alpha/adverse effects/metabolism/*therapeutic use,Lamivudine/metabolism/*therapeutic use,Male,Middle Aged,Reverse Transcriptase Inhibitors/metabolism/*therapeutic use,Treatment Outcome
ISSN: 1007-9327
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Tsianos-2005-interferon a plus.pdf217.28 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons